Betadine desinfizierendes Gurgelkonzentrat

Betadine desinfizierendes Gurgelkonzentrat is a medicine authorised by Swissmedic under authorisation number 34284. The authorisation holder is iNova Pharmaceuticals (Switzerland) AG. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 04 August 1969 and the authorisation is valid without a time limit. ATC code R02AA15 places the medicine in the group Throat preparations.

  • Dispensing category D
  • Authorisation number 34284
  • ATC R02AA15
  • Synthetic medicines
Authorisation data
Authorisation number34284
NameBetadine desinfizierendes Gurgelkonzentrat
Full nameBetadine desinfizierendes Gurgelkonzentrat, Konzentrat zur Herstellung einer Gurgellösung
Authorisation holderiNova Pharmaceuticals (Switzerland) AG
Medicinal product codeSynthetic medicines
Dispensing categoryD · No prescription, with advice
ATC codeR02AA15
First authorisation04 August 1969
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Betadine desinfizierendes Gurgelkonzentrat, Konzentrat zur Herstellung einer GurgellösungD04 August 1969

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
32120mlR02AA1512.03.3.D

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Betadine desinfizierendes Gurgelkonzentrat authorised in Switzerland?

Yes. Betadine desinfizierendes Gurgelkonzentrat is authorised by Swissmedic under authorisation number 34284, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Betadine desinfizierendes Gurgelkonzentrat have?

Betadine desinfizierendes Gurgelkonzentrat is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.

Who is the authorisation holder of Betadine desinfizierendes Gurgelkonzentrat?

The authorisation holder is iNova Pharmaceuticals (Switzerland) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com